This is the authors' abstract. We don't add key points for this paper.
These data demonstrate that proteomic analysis of clinical PDAC liver metastases can identify molecular signatures unique to disease subtypes and point to opportunities for therapeutic development to improve the treatment of PDAC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Law et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: